Brainstorm Cell Therapeutics Inc. (BCLI)
Market Open
11 Aug, 15:44
OTC PINK OTC PINK Primary $
0. 84
+0.05
+6.0544%
$
8.72M Market Cap
- P/E Ratio
- Div Yield
8,437 Volume
-0.7 Eps
$ 0.79
Previous Close Want to track BCLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Brainstorm Cell Therapeutics Inc. (BCLI) Statistics
Valuation metrics
Market Cap 8.72M
Enterprise value 10.19M
Trailing P/E (ttm) -0.84
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) -0.79
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.17
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.81K
Average volume (90 days) 17.44K
Price summary
52-Week low 0.46
52-Week high 1.69
Beta -
50-Day moving average 0.97
200-Day moving average 0.79
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 1 Oct 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -16.76%
Return on equity 1.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -0.14
Current ratio (mrq) 0.02%
Book value per share (mrq) -1.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
